Background

There are tremendous gaps in women’s cancer care in Africa. For example, of the 1.1 million annual reported cases of cancer in Africa, cervical and breast cancer form a significant proportion. Poor awareness in many African countries result in women usually presenting with advanced disease and the vast majority of care is palliative rather than curative. Combined with lack of infrastructure and capacities - Africa has only 3% of the global cancer treatment facilities – results in a significantly higher proportion of cancer related deaths among women on the continent. Although breast and cervical cancer (the top two women’s cancers in emerging markets) have been identified as priorities by the WHO, the cancer disease burden remains high. Mortality from women’s cancers is unacceptably high, leading to many families becoming, or remaining, impoverished.

Working closely with African Health Ministers, the Center for Global Health and Development, along with the National Cancer Institute, the Health Innovation Exchange will convene key members of WHEN, the International Atomic Energy Agency, the United States Department of Energy, and private sector partners, innovators and investors to examine critical gaps in women’s cancer care and determine specific steps required to shift from palliative to preventive and curative care for women across Africa. Partners will also develop a set of critical metrics to measure the impact of public and private partnerships in addressing breast and cervical cancer and the degree to which identified gaps have been addressed and lives saved.

MODERATORS

Joanne Manrique

Joanne Manrique

Chief Executive Officer, CGHD

Edward Trimble, M.D

Edward Trimble, M.D

Senior Advisor for Global HPV and Cervical Research and Control, US NCI

ROUNDTABLE DISCUSSION - VIDEO

PANELISTS

Dr. Edom Seife
Professor, Addis Ababa University

Dr. Mathewos Assefa
Head of Oncology Dept., Tikur Anbessa Specialized Hospital, Ethiopia

Dr. Eva Kantelhardt
Martin Luther-Universität Halle

Stephanie Sassman
Portfolio Leader, Women’s Health, Roche

Dr. Raji Tajudeen
Head, Public Health Institutes & Research Africa CDC

Richard Freeman
Chief of Staff, ADG Simelela WHO

Dr. Ben Anderson
Professor of Surgery and Global Health Medicine, University of Washington Chair, Breast Health Global Initiative, WHO

Nikolas Mezger, M.D.
Research Associate, AFCRN Working Group
Martin Luther University

Mathieu Morand
Senior Manager, Digital and Health Financing, C/Can.

Stephanie Bello
Access and Strategy Leader for LMICs, Roche

Valerie Sinden
Director, Global Government Affairs, Varian

Vipin Yadav
CEO, Dure Technologies

Margo Warren
Head of Policy Access to Medicines Foundation

André Ilbawi, M.D.
Cancer Control Officer, WHO

Dr. Adamu Addissie
Professor
Addis Ababa University

Eric Krakauer, M.D.
Associate Professor of Medicine and Global Health and Social
Medicine, Harvard Medical School

Kee Park, M.D.
Department of Global Health and Social Medicine
Harvard Medical School

SPECIFIC TOPICS FOR DISCUSSION INCLUDE:

  • Strategies for addressing barriers to women’s cancer prevention and treatment access in country including awareness, lack of health workforce, infrastructure and capacities and lack of a holistic solution for cancer care.
  • Steps for augmenting the role of the female health workforce in expanding access to cancer care for breast and cervical cancers.
  • Models for leveraging catalytic funding to empower and equip women to obtain additional oncology skills training and other opportunities for expanding the female oncology health workforce.
  • Strategies and approaches for leveraging technologies and innovation including identifying, developing and deploying innovations to expand access for cancer care and improved efficiencies along the patient pathway (including POC diagnosis, treatment, surgical care etc.).
  • Developing and expanding existing structures, such as community health workers to increase screening and referral for women’s cancers.
  • Development of innovative financing models that could be used to address women’s cancer care and/or promote women’s training in oncology, thereby expanding employment and economic growth for women.
  • Recommendations for data and metrics that will provide critical insight on whether the combined approach of addressing health and economic empowerment has had a positive impact on women seeking and receiving cancer services,

DELIVERABLES

  • Expert recommendations for a metrics implementation plan that will be tested with pilots in two sites.
  • Case studies to highlight key approaches for strengthening the female oncology workforce and building oncology care capacity.
  • Tested innovations that are effective in expanding prevention, early detection, treatment, cure and care for cancer in select countries and a standardized toolkit for cancer care available for expansion to other countries.
  • Launch of a network of women influencers in Africa including female heads of state/government, Ministers (health, finance, gender, innovation etc), private sector leaders, media and public influencers committed to expanding cancer care in Africa.

THE CENTER FOR GLOBAL HEALTH AND DEVELOPMENT (GHD)

2101 L St., NW, Suite 800
Washington, D.C. 20037

tel. +1 (202) 467-8370

ABOUT GHD

The Center for Global Health and Development (GHD) is an international hub for health and development providing a unique platform where global health leaders can engage with other stakeholders to address pressing global health issues.